Besides, variant rs351855‐G/A can lead to germline FGFR4 G388R substitution, subsequently expose a membrane‐proximal STAT3‐binding site and trigger STAT3 signalling cascade, which can accelerate cancer progression and also contribute to tumour‐extrinsic immune evasion.71 This evidence concerns the gene FGFR4 and cancer.